AJP - Cell Physiology, Vol 264, Issue 1 C151-C160, Copyright © 1993 by American Physiological Society

ARTICLES

Altering creatine kinase isoenzymes in transgenic mouse muscle by overexpression of the B subunit

M. J. Brosnan, S. P. Raman, L. Chen and A. P. Koretsky
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.

To change the levels of expression and isoenzyme distribution of creatine kinase (CK) in muscle, transgenic technology was used to express the B subunit of CK in mouse muscle. Normally, mammalian skeletal muscle contains the MM dimer of CK. The BB dimer and MB heterodimer of CK can be found in brain and heart, respectively. Heterologous genes consisting of skeletal and cardiac muscle-specific actin promoters fused to the genomic coding region of the B form of CK were used to create transgenic mice. Lines were established from the three highest expressing founders. Analysis of skeletal muscle extracts revealed that all three lines had an increase in total CK activity measured under maximal velocity conditions. The highest expressing line, 7001, had a CK activity 150% that of control muscle. Nuclear magnetic resonance saturation transfer was used to measure the in vivo rate of the CK reaction. In 7001 hindlimb muscles, the CK catalyzed reaction was 200% that of control muscle. The elevation in CK activity in transgenic muscle was accompanied by significant changes in the composition of the cytosolic isoenzyme ratio of CK. In control, 100% of CK was MM, whereas 7001 had 60 +/- 18% MM, 32 +/- 10% MB, and 8 +/- 2% BB. There were no changes in ATP, phosphocreatine, Pi, or creatine levels in transgenic muscle compared with control. Immunofluorescence of myofibrils isolated from control and transgenic muscle revealed specific association of CK to the M line. Small amounts of MB CK were detected on myofibrils from transgenic mice. Transgenic mice expressing the B subunit of CK in muscle represent a first step toward altering CK isoforms so as to elucidate the specific roles of these isoforms in energy metabolism.

This article has been cited by other articles:

				N. Cros, J. Muller, S. Bouju, G. Pietu, C. Jacquet, J. J. Leger, J.-F. Marini, and C. A. Dechesne Upregulation of M-creatine kinase and glyceraldehyde3-phosphate dehydrogenase: two markers of muscle disuse Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R308 - R316. [Abstract] [Full Text] [PDF]

				J. James and J. Robbins Molecular remodeling of cardiac contractile function Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2105 - H2118. [Abstract] [Full Text] [PDF]

				B. B. Roman, B. Wieringa, and A. P. Koretsky Functional Equivalence of Creatine Kinase Isoforms in Mouse Skeletal Muscle J. Biol. Chem., July 11, 1997; 272(28): 17790 - 17794. [Abstract] [Full Text] [PDF]

				N. Askenasy and A. P. Koretsky Transgenic livers expressing mitochondrial and cytosolic CK: mitochondrial CK modulates free ADP levels Am J Physiol Cell Physiol, February 1, 2002; 282(2): C338 - C346. [Abstract] [Full Text] [PDF]